Effect of SGLT2i on Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients

Clinical trial NCT05310916 · UNKNOWN

Trial details

NCT number: NCT05310916
Sponsor: Nidae Alaa
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetic Retinopathy

Start date: 2022-06-06
Primary completion: 2023-05-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.